148 related articles for article (PubMed ID: 22124516)
1. Endotracheal DNase for atelectasis in ventilated neonates.
MacKinnon R; Wheeler KI; Sokol J
J Perinatol; 2011 Dec; 31(12):799-801. PubMed ID: 22124516
[TBL] [Abstract][Full Text] [Related]
2. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis.
Merkus PJ; de Hoog M; van Gent R; de Jongste JC
Eur Respir J; 2001 Oct; 18(4):734-7. PubMed ID: 11716180
[TBL] [Abstract][Full Text] [Related]
3. Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?
McLaughlin AM; McGrath E; Barry R; Egan JJ; Gallagher CG
Clin Respir J; 2008 Apr; 2(2):123-6. PubMed ID: 20298317
[TBL] [Abstract][Full Text] [Related]
4. Comparing the efficacy of nebulizer recombinant human DNase and hypertonic saline as monotherapy and combined treatment in the treatment of persistent atelectasis in mechanically ventilated newborns.
Altunhan H; Annagür A; Pekcan S; Ors R; Koç H
Pediatr Int; 2012 Feb; 54(1):131-6. PubMed ID: 22114907
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: case-series.
Erdeve O; Uras N; Atasay B; Arsan S
Croat Med J; 2007 Apr; 48(2):234-9. PubMed ID: 17436388
[TBL] [Abstract][Full Text] [Related]
6. Resolution of recurrent atelectasis in spinal cord injury patients with administration of recombinant human DNase.
Voelker KG; Chetty KG; Mahutte CK
Intensive Care Med; 1996 Jun; 22(6):582-4. PubMed ID: 8814475
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant human DNase in conditions other than cystic fibrosis].
Kristensen K
Ugeskr Laeger; 2010 Feb; 172(8):616-9. PubMed ID: 20184817
[TBL] [Abstract][Full Text] [Related]
8. Safety of endotracheal rh DNAse (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children.
Boeuf B; Prouix F; Morneau S; Marton D; Lacroix J
Pediatr Pulmonol; 1998 Aug; 26(2):147. PubMed ID: 9727769
[No Abstract] [Full Text] [Related]
9. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates.
El Hassan NO; Chess PR; Huysman MW; Merkus PJ; de Jongste JC
Pediatrics; 2001 Aug; 108(2):468-70. PubMed ID: 11483817
[TBL] [Abstract][Full Text] [Related]
10. Clinical and in vitro effect of dornase alfa in mechanically ventilated pediatric non-cystic fibrosis patients with atelectases.
Riethmueller J; Kumpf M; Borth-Bruhns T; Brehm W; Wiskirchen J; Sieverding L; Ankele C; Hofbeck M; Baden W
Cell Physiol Biochem; 2009; 23(1-3):205-10. PubMed ID: 19255515
[TBL] [Abstract][Full Text] [Related]
11. Cystic fibrosis: an unusual neonatal presentation.
Sankaran K; Kalapurackal M; Wiebe S
Pediatr Pulmonol; 2012 Jun; 47(6):620-2. PubMed ID: 22266831
[TBL] [Abstract][Full Text] [Related]
12. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
[TBL] [Abstract][Full Text] [Related]
13. Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns.
Dilmen U; Karagol BS; Oguz SS
Pediatr Int; 2011 Jun; 53(3):328-31. PubMed ID: 20831650
[TBL] [Abstract][Full Text] [Related]
14. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.
Slattery DM; Waltz DA; Denham B; O'Mahony M; Greally P
Pediatr Pulmonol; 2001 May; 31(5):383-8. PubMed ID: 11340685
[TBL] [Abstract][Full Text] [Related]
15. [Intensive therapy for several emergency conditions in pediatric pulmonology].
Rokitskiĭ MR; Zhavoronkov VF; Poryvaeva VN
Khirurgiia (Mosk); 1972 Jun; 48(6):10-4. PubMed ID: 5043039
[No Abstract] [Full Text] [Related]
16. Recombinant human deoxyribonuclease improves atelectasis in mechanically ventilated children with cardiac disease.
Prodhan P; Greenberg B; Bhutta AT; Hyde C; Vankatesan A; Imamura M; Jaquiss RD; Dyamenahalli U
Congenit Heart Dis; 2009; 4(3):166-73. PubMed ID: 19489944
[TBL] [Abstract][Full Text] [Related]
17. Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns.
Fedakar A; Aydogdu C; Fedakar A; Ugurlucan M; Bolu S; Iskender M
Ann Saudi Med; 2012; 32(2):131-6. PubMed ID: 22366825
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human deoxyribonuclease shortens ventilation time in young, mechanically ventilated children.
Riethmueller J; Borth-Bruhns T; Kumpf M; Vonthein R; Wiskirchen J; Stern M; Hofbeck M; Baden W
Pediatr Pulmonol; 2006 Jan; 41(1):61-6. PubMed ID: 16265663
[TBL] [Abstract][Full Text] [Related]
19. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus.
Durward A; Forte V; Shemie SD
Crit Care Med; 2000 Feb; 28(2):560-2. PubMed ID: 10708200
[TBL] [Abstract][Full Text] [Related]
20. [Tracheal intubation and artificial ventilation in severe acute respiratory insufficiency in infants and children].
Pancu V; Burduja Z; Burduja E
Rev Med Chir Soc Med Nat Iasi; 1973; 77(1):169-77. PubMed ID: 4793188
[No Abstract] [Full Text] [Related]
[Next] [New Search]
